Results 1 to 10 of about 718 (153)

Alterations in ROS Activity and Lysosomal pH Account for Distinct Patterns of Macroautophagy in LINCL and JNCL Fibroblasts [PDF]

open access: yesPLoS ONE, 2013
Neuronal ceroid lipofuscinoses (NCL) are lysosomal storage disorders characterized by the accumulation of lipofuscin within lysosomes. Late infantile (LINCL) and juvenile (JNCL) are their most common forms and are caused by loss-of-function mutations in ...
Carmen Aguado   +2 more
exaly   +8 more sources
Some of the next articles are maybe not open access.

Studies of Atypical JNCL Suggest Overlapping With Other NCL Forms

Pediatric Neurology, 1998
In the United States, juvenile neuronal ceroid-lipofuscinosis (JNCL) is the most common form of NCL. This study analyzed 191 cases, diagnosed on the basis of age-at-onset, clinical symptomatology, and pathologic findings. Twenty percent (40/191) of these cases from 24/120 families manifested atypical clinical symptomatology and/or pathologic findings ...
Wojciech Kaczmarski   +2 more
exaly   +3 more sources

5 Positional Cloning of the JNCL Gene, CLN3

Advances in Genetics, 2001
Terry J Lerner
exaly   +2 more sources

JNCL Patients Show Marked Brain Volume Alterations on Longitudinal MRI in Adolescence

Journal of Neurology, 2008
Juvenile neuronal ceroid lipofuscinosis (JNCL, CLN3) is an inherited lysosomal disease. We used longitudinal MRI, for the first time, to evaluate the rate of brain volume alterations in JNCL. Six patients (mean ages of 12.4 years and 17.3 years) and 12 healthy controls were studied twice with 1.5 T MRI.
Koen Van Leemput, Minna Mannerkoski
exaly   +3 more sources

Decreased Striatal Dopamine Transporter Density in JNCL Patients With Parkinsonian Symptoms

Neurology, 2000
To explore whether striatal dopamine transporters are involved in juvenile neuronal ceroid lipofuscinosis (JNCL) with extrapyramidal signs.Seventeen patients with JNCL entered the study (mean age, 15 years; age range, 10 to 31 years). For clinical evaluation, the authors used the motor section of the Unified Parkinson's Disease Rating Scale (UPDRS ...
Juha O. Rinne   +2 more
exaly   +3 more sources

Defective Intracellular Transport of CLN3 Is the Molecular Basis of Batten Disease (JNCL) [PDF]

open access: yesHuman Molecular Genetics, 1999
Batten disease [juvenile-onset neuronal ceroid lipofuscinosis (JNCL)], the most common progressive encephalopathy of childhood, is caused by mutations in a novel lysosomal membrane protein (CLN3) with unknown function. In this study, we have confirmed the lysosomal localization of the CLN3 protein by immunoelectron microscopy by co-localizing it with ...
Irma Järvelä   +2 more
exaly   +3 more sources

Evaluation of the Possible Role of Coenzyme Q10 and Vitamin E in Juvenile Neuronal Ceroid-Lipofuscinosis (JNCL)

Molecular Aspects of Medicine, 1997
The juvenile type of neuronal ceroid lipofuscinosis (JNCL) is a recessively inherited, progressive neurodegenerative disease. In this study the levels of the antioxidant factors coenzyme Q10 (CoQ10) and vitamin E (alpha-tocopherol) were measured in plasma samples of 29 JNCL patients and compared to 48 healthy controls.
T Westermarck   +2 more
exaly   +3 more sources

Juvenile Neuronal Ceroid Lipofuscinosis (JNCL): Quantitative Description of Its Clinical Variability

Acta Paediatrica, International Journal of Paediatrics, 1988
ABSTRACT. The clinical courses of 17 JNCL patients were analyzed retrospectively with the use of a simple, disease‐specific scoring system. The mean observation period was 14 years (range 8–18 years). Scores of 0 (maximal dysfunction) to 3 (normal function) were assigned to each patient's vision, intellect ...
Alfried Kohlschütter, M Albani
exaly   +3 more sources

Novel CLN3 Mutation Predicted to Cause Complete Loss of Protein Function Does Not Modify the Classical JNCL Phenotype

Neuroscience Letters, 2005
Juvenile Neuronal Ceroid Lipofuscinosis (JNCL), or Batten disease, is a childhood neurodegenerative disease that is characterized clinically by progressive visual loss, seizures, dementia, and motor incoordination. Children affected with this disease tend to develop normally for the first 5 years of life.
David A Pearce   +2 more
exaly   +3 more sources

Methodology of Clinical Research in Rare Diseases: Development of a Research Program in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) via Creation of a Patient Registry and Collaboration With Patient Advocates [PDF]

open access: yesContemporary Clinical Trials, 2013
Juvenile neuronal ceroid lipofuscinosis (JNCL; Batten disease) is a rare, inherited, fatal lysosomal storage childhood disorder. True for many rare diseases, there are no treatments that impact the course of JNCL. The University of Rochester Batten Center's (URBC) mission is to find treatments to slow, halt, or prevent JNCL.Our initial objective was to
Erika F. Augustine   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy